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Abstract
Background: Multi-drug-resistant Tuberculosis (MDR-TB) remains a public health problem in developing 
countries such as Indonesia. The extensive parenchymal damage due to MDR-TB could manifest as an irreversible 
destroyed lung, leading to respiratory and  also cardiovascular complication. Its occurrence in pregnancy is 
uncommon but is highly associated with higher mortality and morbidity for both maternal and fetal.
Case Report: We report a case of 24 year old primigravida in National Respiratory Center Hospital, diagnosed with 
an unilateral destroyed lung due to MDR-TB in pregnancy at 32 weeks of gestational age. On initial presentation, 
she reported fatigue, nausea, night sweats, chronic dyspnoe and was found to have complete left destroyed lung. 
Her disease was managed during pregnancy using long-term oxygen therapy despite persistent desaturation.
Conlusion: Aside from frequent monitoring, prolonged oxygen therapy might benefit the chronic hypoxia 
condition in gestational destroyed lung due to previous MDR-TB infection, for preventing maternal-fetal mortality 
and morbidities, such as respiratory failure and IUGR.
Tuberkulosis MDR rekuren dengan Kerusakan paru unilateral 
dalam kehamilan : Sebuah laporan kasus
Abstrak
Latar Belakang: Tuberkulosis Multi-drug-resistant (TB-MDR) tetap menjadi masalah kesehatan pada negara 
berkembang, seperti Indonesia. Kerusakan parenkin luas yang diakibatkan oleh infeksi TB-MDR dapat 
bermanifestasi sebagai kerusakan paru ireversibel, dengan komplikasi respiratorik dan kardiovaskular. Kejadian 
kerusakan paru akibat TB-MDR dalam kehamilan jarang terjadi, namun berdampak pada peningkatan mortalitas 
dan morbiditas pada janin dan ibu. 
Laporan Kasus: Studi ini melaporkan kasus perempuan primigravida 24 tahun didiagnosa dengan kerusakan paru 
unilateral akibat infeksi TB-MDR pada kehamilan 32 minggu di RS Pusat Paru Nasional. Pada pemeriksaan awal, 
didapatkan pasien mengeluhkan kelelahan kronik, nausea, keringat malam, sesak kronik dan didapatkan memiliki 
kerusakan paru kiri komplit. Keadaan pasien dalam kehamilan ditatalaksana dengan terapi oksigen jangka panjang 
untuk mengatasi desaturasi persisten 
Kesimpulan: Di samping pengawasan ketat, terapi oksigen jangka panjang dapat menjadi tatalaksana utama untuk 
kondisi hipoksia kronik pada kerusakan paru dalam kehamilan akibat infeksi lama TB-MDR untuk mencegah 
morbiditas dan mortalitas ibu dan janin, seperti gagal napas dan pertumbuhan janin terhambat  (PJT).
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Introduction
Multi-drug resistant tuberculosis (MDR-TB) 
is defined as tuberculosis infection resistant 
to at least rifampicin and isoniazid. Indonesia, 
with approximately 6,800 new cases every 
year, is one of the 27 MDR-TB high burden 
countries worldwide.113% of MDR-TB cases 
in Indonesia have been received previous TB 
treatment.2As much as 1.860 patients were 
confirmed MDR-TB in Indonesia.3MDR-TB 
affects young adults, including child-bearing 
age women.4The understanding of teratogenic 
properties of second-line drugs is not fully 
established yet negligence of treatment 
would lead to higher risk of maternal and 
fetal mortality and morbidity. 
If not well managed, the extensive 
parenchymal damage of the infection could 
manifest as destroyed lung, defined as a 
total destruction of the lung secondary 
to recurrent or chronic lung infection.  A 
destroyed lung causes chronic airway 
obstruction as well as restrictive change, 
pulmonary hypertension,and left-right shunt. 
The destroyed lung architecture is easily 
colonised by bacteria and fungi, increasing 
the risk of recurrent infection thus higher 
morbidity and mortality.5,6
Case presentation
A 26-year-old primigravida at 32-week 
period of gestation (POG) presenting with 
progressive dyspnea (12 hours) was admitted. 
Other symptoms were chest pain, productive 
cough, fever, and swollen extremities. She 
had history of MDR –TB and had been 
completed her treatment for 6 months prior 
to admission and now in long term oxygen 
therapy. She was consulted to Ob-Gyn due 
to contraction (4 hours) without any vaginal 
discharge. 
On admission, she was fully conscious, 
blood pressure was 99/65 mmHg, heart rate 
was 110 /min, temperature was 37.5 °C, 
respiratory rate was 26 /min, and oxygen 
saturation was 83% at room air and was 92% 
at 4 lpm by nasal cannula. She weighed 35 
kg and her height was 150 cm (body mass 
index = 15.5 kg/m2). Pale conjunctiva and 
enlarged bilateral submandibular lymph node 
were positive. Thorax examination revealed 
collapsed left hemithorax, decreased left 
vesicular sound, bilateral ronchi, and 
trachea was deviated to the left with coarse 
crepitations and bronchial breath sounds over 
left hemithorax. Fundal height was 23 cm, 
cephalic presentation, fetal heart rate at 148 
/ min. Contraction was observed four times 
every 10 minutes for 40 seconds. 
Cardiotocography result was category 
1. Ultrasound revealed EFW 1703 gr,BPD 
82, HC 287, AC 276, FL 61, showing 
accordance to 32-33 wga with reduced 
amniotic volume AFI 8.5, SDAU 2.8, PI 
1.08, MCA PI 1.52, CRP >1. Blood test 
revealed microcytic hypochromic anemia 
with Hb of 7.8 g/dl, hypoalbuminemia 
(2.4 g/dl), and hyponatremia (125 mEq/L). 
Chest x-ray showedinfiltrates at right lung, 
bronchiectasis, collapsed left lung with 
pleural line , fibrocystic changes, complete 
shift of the tracheal air column to the left and 
compensatory hyperinflation of the right lung 
(figure 1). Sputum test revealed resistance 
to Rifampicin.Gene Xpert showed positive 
result.
Doppler limb ultrasound revealed 
oedema with no abnormality of the vein. 
Echocardiography result showed dilatation 
of right atrium and right ventricle, normal 
LVEF of 67%, reduced right ventricle 
contractility (TAPSE 0.42 cm), severe 
tricuspid regurgitation with high probability 
of pulmonary hypertension, and moderate 
pulmonary regurgitation. The assesment 
was preterm labor contraction with tocolytic 
score of 4, reccurent multi-drug tuberculosis 
with unilateral destroyed lung.
Treatments given were daily intravenous 
fluid, parenteral nutrition, 4 course of 
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dexamethasone for fetal lung maturation, 
intravenous ampicillin-sulbactam, oral 
treatments of albumin, folic acid, calcium, 
cholecalciferol, ferrous sulphate, sodium 
chloride,  vitamin B complex. She received 
blood transfusion (2 units packed red cells) 
with Hb target of 11 g/dl. Taken care by 
Pulmonology Department, patient was given 
oxygen therapy, screening and sputum culture 
were negative, acid-alcohol fast-bacilli were 
positive on Ziehl-Neelsen staining.
3 days later she delivered spontaneously after 
preterm premature rupture of membrane, with 
baby weighing 1700 gr (centile 10th – 50th, 
Intergrowth chart) , with good Apgar score 
of 7 and 8,with reduced clear amniotic fluid. 
No major congenital anomalies has seen in 
baby. The baby was admitted to NICU with 
CPAP PEEP 7, FiO2 21% and saturation of 
97%. The baby was discharged 35 days after 
hospitalizations, given prophylactic isoniazid. 
Mother and babies were fine on follow-up 12 
weeks after delivery , mother was given long-
term oxygen therapy (LTOT); high-flow 
nasal canula, portable oxygen delivery with 
oxygen conserving devices.
Discussion
MDR-TB treatment in pregnancy is a very 
challenging condition in which no therapy 
guideline has been established. Almost all 
second line anti-TB drugs fall under category 
C except aminoglycosides (category D). 
Treatment is individualized based on drug 
resistance pattern. There have been studies 
promoting the benefits of treatment that 
outweigh the risks to the mother and fetus.7,8 
However, large-scale study about efficacy 
and toxicity is still absent. On the other hand, 
late initiation on treatment was reported to 
have higher rate of preterm labor and neonatal 
complications compared to early treatment or 
non-TB pregnant patients and there is higher 
risk of postpartum vertical transmission due 
to slower conversion rate in MDR-TB case.9,10
Patient’s history of MDR-TB was the origin 
of her left destroyed lung, which further 
complicated her pregnancy. Destroyed 
lung often leads to chronic hypoxemia, 
whose main effect to the fetus is failure to 
achieve its potential growth, i.e. intrauterine 
growth restriction (IUGR). IUGR fetus 
have higher risk of distress, asphyxia, and 
 
a b 
Figure 1 (a) x-ray on 18th month of MDR-TB treatment. (b) current xray 
showing collapsed left lung and pleural line
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perinatal mortality and morbidity, as well 
as fetal origins of adult disease for longterm 
complications.11Patient’s oxygen saturation 
in room air was only 83%, thererefore she 
was given long-term oxygen therapy and 
upon admission she was with 4 lpm of oxygen 
through nasal cannula, with target oxygen 
saturation was maximum 92%.In practice, 
real-time monitoring of PaO2 is not usually 
possible and therefore a target SaO2 range 
of 88%–92% is now generally accepted 
for those patients at risk of hypercapnia. 
Allowing for individual variations in the 
oxygen dissociation curve, these will correct 
hypoxia to a safe level and minimize the risk 
of oxygen-induced hypercapnia.
Although there was reduced amniotic 
fluid which could be initial symptom of 
growth restriction, fetal ultrasound still 
showed normal growth and activity. This 
shows that oxygen therapy might be beneficial 
to prevent further sequalae of fetal hypoxia. 
This is in accordance with Nicolaides, et 
al  reporting the benefit of maternal oxygen 
therapy for increasing fetal pO2 to ameliorate 
growth restriction.12While patient also had 
anemia of chronic disease as another risk 
factor of fetal hypoxia, it is known for less 
deleterious effect for the fetal since  higher 
oxygen affinity of fetal haemoglobin will be 
compensatory. Fetus is also able to increase 
cardiac output to increase transplacental 
oxygen transfer by interfering with the iron 
metabolism of the mother.11
Aside from maintaining adequate 
oxygen, decision about whether to conserve 
or terminate the pregnancy in this case was 
also challenging. The decision case should 
be based on IUGR management approach. 
Once small fetus is identified, measurement 
of UtA PI, UA PI, MCA PI, and CPR should 
be performed to distinguish between SGA 
and IUGR, as well as to classify the stage 
of growth restriction. In this case, reduced 
amnion fluid could be the sign of mild 
placental insufficiency, which fall into 
first stage of IUGR. Monitoring should be 
performed weekly and labor induction should 
be offered at 37 wga.13 However, this patient 
had preterm premature rupture of membrane 
and had preterm birth. 
Pneumonectomy is recommended 
for destroyed lung butplanned surgery is 
recommended due to higher morbidityand 
mortality in emergency cases; this explains 
there’s no plan from Pulmonology 
Department yet about the surgery because it 
was suggested to patients whose contralateral 
lung is healthy,  with no sign of reccurency 
or relaps. 
Conclusion
Aside from frequent monitoring, long-term 
oxygen therapy might benefit the chronic 
hypoxia condition in gestational destroyed 
lung due to previous MDR-TB infection, 
for preventing maternal-fetal mortality and 
morbidities, such as respiratory failure and 
IUGR.
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